ResMed documented nearly 1.95 million of its own CPAP patients who also hold GLP-1 prescriptions, a figure that suggests co-therapy rather than substitution is the dominant near-term pattern
We understand that new treatments like retatrutide are exciting, but until they receive proper approvals, we remain committed to offering solutions that are both cutting-edge and trustworthy
That distinction matters because once GLP-1s are framed as longevity drugs rather than treatments for specific medical conditions, people may increasingly turn to unregulated, compounded versions that arent made by the manufacturers of brand-name drugs
Novo Nordisk, who makes Wegovy and Ozempic, has worked to ramp up production
You may inject in the same body area each week, but it is important to use a different spot each time
I had EVLT last January 29 on my left leg